CLINICAL_TRIALS ClinicalTrials.gov record update

Study of Administration of Intravenous Naglazyme® Following Allogeneic Transplantation for Maroteaux-Lamy Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02156674
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:53.181218+00:00
Published At: 2020-12-23T00:00:00+00:00
Record Updated At: 2020-12-23
Results Posted At: 2020-12-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Maroteaux-Lamy Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-12-23"
protocolSection.identificationModule.nctId: "NCT02156674"
protocolSection.identificationModule.officialTitle: "Study of Administration of Intravenous Naglazyme\u00ae Following Allogeneic Transplantation for Maroteaux-Lamy Syndrome"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-12-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.